Jose Luis Lopez-Hontangas
Overview
Explore the profile of Jose Luis Lopez-Hontangas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
224
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lozano N, Lloret-Sos C, Gimenez-Marti M, Sahuquillo-Arce J, Gomez-Ruiz M, Trelis M, et al.
Acta Trop
. 2024 Nov;
260:107458.
PMID: 39522577
Chagas disease (CD), caused by the flagellate protozoan parasite Trypanosoma cruzi, is endemic in 21 American countries. It is estimated that about 6-8 million people are infected. Nevertheless, CD should...
2.
Suarez-Urquiza P, Peman J, Gordon M, Favier P, Munoz-Brell P, Lopez-Hontangas J, et al.
J Fungi (Basel)
. 2024 Oct;
10(10).
PMID: 39452626
Fungemia remains a major threat in intensive care units (ICUs), with high mortality rates despite advances in diagnostics and treatment. Colonisation by yeasts is an independent risk factor for fungemia;...
3.
Carmona-Salido H, Lopez-Solis S, Lopez-Hontangas J, Amaro C
J Infect Dis
. 2024 Oct;
PMID: 39405190
Background: In recent years, we have witnessed an unprecedented increase in the incidence of vibriosis due to global warming. Vibrio metoecus is a recently described V. cholerae-like species that has...
4.
Garrido-Jareno M, Roig-Sena F, Perez-Perez E, Gil-Brusola A, Lopez-Hontangas J, Valentin-Gomez E, et al.
Diagn Microbiol Infect Dis
. 2024 Sep;
110(4):116532.
PMID: 39278134
Background: Invasive pneumococcal disease (IPD) remains a significant concern among children under 5, despite vaccination efforts. This study assessed IPD prevalence and associated risks in pediatric population. Methods: An observational,...
5.
Valdivieso-Martinez B, Lopez-Sanchez V, Sauri I, Diaz J, Calderon J, Gas-Lopez M, et al.
JMIR Public Health Surveill
. 2024 Sep;
10:e53580.
PMID: 39226091
Background: Following the initial acute phase of COVID-19, health care resource use has escalated among individuals with SARS-CoV-2 infection. Objective: This study aimed to compare new diagnoses of long COVID...
6.
Tortosa-Carreres J, Lloret-Sos C, Sahuquillo-Arce J, Suarez-Urquiza P, Prat-Fornells J, Molina-Moreno J, et al.
Diagn Microbiol Infect Dis
. 2024 Jan;
108(3):116167.
PMID: 38176302
The present investigation assessed the Liaison® diagnostic performance in detecting Epstein-Barr (EBV) IgM-VCA in a large patient cohort, considering age and symptomatology. VIDAS® were employed as a benchmark for acute...
7.
Garcia-Marin A, Cancino-Munoz I, Torres-Puente M, Villamayor L, Borras R, Borras-Manez M, et al.
Lancet Microbe
. 2023 Dec;
5(1):e43-e51.
PMID: 38061383
Background: In June, 2021, WHO published the most complete catalogue to date of resistance-conferring mutations in Mycobacterium tuberculosis. Here, we aimed to assess the performance of genome-based antimicrobial resistance prediction...
8.
Sahuquillo-Arce J, Reyes-Prieto M, Hernandez-Cabezas A, Molina-Moreno J, Saez-Nieto J, Marin M, et al.
Int J Syst Evol Microbiol
. 2023 Aug;
73(8).
PMID: 37605998
Strain HF14-78462 is an environmental bacterium found in clinical samples from an immunocompromized patient in 2014 at Hospital Universitari i Politècnic La Fe (Valencia, Spain). Phenotypically, strain HF14-78462 cells were...
9.
Garrido-Jareno M, Sahuquillo-Arce J, Rodriguez-Vega H, Lloret-Sos C, Gil-Brusola A, Lopez-Hontangas J, et al.
Med Microbiol Immunol
. 2023 Jan;
212(1):93-102.
PMID: 36595027
Measurement of anti-pneumococcal capsular polysaccharides (anti-PnPs) IgG titers is an important tool in the immunologic assessment of patients with suspected immunodeficiency disorders (ID) to reduce the morbi-mortality and minimize severe...
10.
Djukovic A, Garzon M, Canlet C, Cabral V, Lalaoui R, Garcia-Garcera M, et al.
Nat Commun
. 2022 Sep;
13(1):5617.
PMID: 36153315
Infections by multidrug-resistant Enterobacteriaceae (MRE) are life-threatening to patients. The intestinal microbiome protects against MRE colonization, but antibiotics cause collateral damage to commensals and open the way to colonization and...